Curcumin preconditioning enhances the efficacy of adipose-derived mesenchymal stem cells to accelerate healing of burn wounds.
Acidic burn
Adipose-derived stem cells
Curcumin preconditioning
Wound healing
Journal
Burns & trauma
ISSN: 2321-3868
Titre abrégé: Burns Trauma
Pays: England
ID NLM: 101651457
Informations de publication
Date de publication:
2021
2021
Historique:
received:
05
01
2021
revised:
26
03
2021
entrez:
13
9
2021
pubmed:
14
9
2021
medline:
14
9
2021
Statut:
epublish
Résumé
Following recent findings from our group that curcumin preconditioning augments the therapeutic efficacy of adipose-derived stem cells in the healing of diabetic wounds in rats, we aimed to investigate the regenerative effects of curcumin preconditioned adipose-derived mesenchymal stem cells (ASCs) for better recovery of acid inflicted burns in this study. ASCs were preconditioned with 5 μM curcumin for 24 hours and assessed for proliferation, migration, paracrine release potential and gene expression comparative to naïve ASCs. Subsequently, the healing capacity of curcumin preconditioned ASCs (Cur-ASCs) versus naïve ASCs was examined using acidic wounds in rats. For this, acid inflicted burns of 20 mm in diameter were made on the back of male Wistar rats. Then, 2 × 10 We found that Cur-ASCs exhibited greater proliferation, migration and paracrine potential Treatment with Cur-ASCs resulted in faster re-epithelization of acid inflicted burns compared to the treatment with naïve ASCs. Based on observed findings, we suggest the transplantation of Cur-ASCs is a valuable therapy for the potent clinical management of acidic burns.
Sections du résumé
BACKGROUND
BACKGROUND
Following recent findings from our group that curcumin preconditioning augments the therapeutic efficacy of adipose-derived stem cells in the healing of diabetic wounds in rats, we aimed to investigate the regenerative effects of curcumin preconditioned adipose-derived mesenchymal stem cells (ASCs) for better recovery of acid inflicted burns in this study.
METHODS
METHODS
ASCs were preconditioned with 5 μM curcumin for 24 hours and assessed for proliferation, migration, paracrine release potential and gene expression comparative to naïve ASCs. Subsequently, the healing capacity of curcumin preconditioned ASCs (Cur-ASCs) versus naïve ASCs was examined using acidic wounds in rats. For this, acid inflicted burns of 20 mm in diameter were made on the back of male Wistar rats. Then, 2 × 10
RESULTS
RESULTS
We found that Cur-ASCs exhibited greater proliferation, migration and paracrine potential
CONCLUSIONS
CONCLUSIONS
Treatment with Cur-ASCs resulted in faster re-epithelization of acid inflicted burns compared to the treatment with naïve ASCs. Based on observed findings, we suggest the transplantation of Cur-ASCs is a valuable therapy for the potent clinical management of acidic burns.
Identifiants
pubmed: 34514007
doi: 10.1093/burnst/tkab021
pii: tkab021
pmc: PMC8430278
doi:
Types de publication
Journal Article
Langues
eng
Pagination
tkab021Informations de copyright
© The Author(s) 2021. Published by Oxford University Press.
Références
Cell Transplant. 2016;25(1):71-81
pubmed: 25853951
Mol Cell Biochem. 2018 Aug;445(1-2):195-210
pubmed: 29305678
Stem Cells Transl Med. 2014 Dec;3(12):1514-25
pubmed: 25313202
J Cardiovasc Pharmacol. 2010 Apr;55(4):377-84
pubmed: 20125031
Genes Dis. 2019 Sep 17;6(4):342-358
pubmed: 31832514
PLoS One. 2010 Mar 04;5(3):e9539
pubmed: 20209061
Ann Burns Fire Disasters. 2017 Dec 31;30(4):243-246
pubmed: 29983673
Stem Cell Res Ther. 2020 May 24;11(1):197
pubmed: 32448356
Stem Cell Res Ther. 2019 Mar 29;10(1):111
pubmed: 30922387
Mol Pathol. 2002 Jun;55(3):164-76
pubmed: 12032227
Stem Cells Int. 2020 Feb 17;2020:4636397
pubmed: 32148518
Drug Des Devel Ther. 2015 Sep 25;9:5337-44
pubmed: 26445530
J Biomater Appl. 2019 Oct;34(4):463-475
pubmed: 31262210
Stem Cells Int. 2018 May 20;2018:6901983
pubmed: 29887893
Int J Mol Sci. 2019 May 22;20(10):
pubmed: 31121953
Burns. 2012 May;38(3):383-7
pubmed: 22037150
J Mol Histol. 2013 Feb;44(1):83-90
pubmed: 23054142
Wound Repair Regen. 2014 May-Jun;22(3):313-25
pubmed: 24844331
Pharmacol Res. 2008 Aug;58(2):165-71
pubmed: 18617006
Oxid Med Cell Longev. 2018 Sep 20;2018:3295807
pubmed: 30327711
Antioxid Redox Signal. 2009 Feb;11(2):241-9
pubmed: 18976114
Stem Cell Res Ther. 2020 Oct 8;11(1):434
pubmed: 33032649
Biochem Biophys Res Commun. 2013 Nov 8;441(1):191-5
pubmed: 24140062
Nutr Metab (Lond). 2011 Nov 17;8(1):80
pubmed: 22088091
Acta Neurobiol Exp (Wars). 2018;78(4):358-374
pubmed: 30624435
Sci Rep. 2020 Jan 31;10(1):1572
pubmed: 32005848
J Vasc Surg. 2018 Dec;68(6S):115S-125S
pubmed: 29753580
Stem Cell Res Ther. 2016 Aug 16;7(1):114
pubmed: 27526687
Stem Cell Res Ther. 2017 Dec 22;8(1):289
pubmed: 29273091
Burns. 2015 May;41(3):484-92
pubmed: 25440856
Cardiovasc Toxicol. 2011 Dec;11(4):357-64
pubmed: 21769543
Nat Commun. 2020 May 18;11(1):2470
pubmed: 32424320
J Int Med Res. 2020 Apr;48(4):300060520910665
pubmed: 32237999
Stem Cells Transl Med. 2013 Jul;2(7):545-51
pubmed: 23734060
Ocul Surf. 2016 Apr;14(2):121-34
pubmed: 26804815
Front Physiol. 2016 Feb 09;7:24
pubmed: 26903875
Cardiovasc Res. 2008 Jan;77(1):134-42
pubmed: 18006467
Immunobiology. 2011 Jul;216(7):753-62
pubmed: 21281986
Int J Mol Sci. 2014 Oct 08;15(10):17974-99
pubmed: 25299695
J Pharmacol Sci. 2016 Nov;132(3):192-200
pubmed: 27840063
J Cell Mol Med. 2019 Feb;23(2):720-730
pubmed: 30484934
Growth Factors. 2017 Oct;35(4-5):144-160
pubmed: 29110545
Cells. 2020 Jan 28;9(2):
pubmed: 32012802
Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1872-80
pubmed: 23766261
Nat Rev Nephrol. 2018 Aug;14(8):493-507
pubmed: 29895977
Mol Cell Biochem. 2018 Jun;443(1-2):37-45
pubmed: 29052798
Lancet. 2010 Oct 9;376(9748):1209-10
pubmed: 20941859
Drug Des Devel Ther. 2016 Mar 29;10:1267-77
pubmed: 27099472
Drug Res (Stuttg). 2018 Apr;68(4):213-221
pubmed: 29017189
Stem Cells Int. 2015;2015:734731
pubmed: 26300923
Stem Cells Transl Med. 2019 Apr;8(4):404-414
pubmed: 30624028
Stem Cell Res Ther. 2018 Nov 8;9(1):302
pubmed: 30409218
Wound Repair Regen. 2016 Mar;24(2):215-22
pubmed: 26704519
Arch Surg. 2010 Mar;145(3):259-66
pubmed: 20231626
Tissue Eng Part A. 2016 Feb;22(3-4):295-305
pubmed: 26871860
Stem Cell Res Ther. 2018 Aug 23;9(1):225
pubmed: 30139368
Stem Cell Res Ther. 2018 May 15;9(1):142
pubmed: 29764508
Antioxid Redox Signal. 2014 Mar 1;20(7):1126-67
pubmed: 23991888
Adv Wound Care (New Rochelle). 2012 Aug;1(4):166-171
pubmed: 24527299
Tissue Eng Part B Rev. 2020 Dec;26(6):555-570
pubmed: 32242479
Stem Cells Int. 2020 Jan 9;2020:7056261
pubmed: 32399048
Stem Cells Int. 2015;2015:638153
pubmed: 26074974
Oxid Med Cell Longev. 2015;2015:632902
pubmed: 25722795
Life Sci. 2020 Sep 15;257:118091
pubmed: 32668325
Int J Mol Sci. 2016 Dec 11;17(12):
pubmed: 27973441